Linkage and association has been reported between CTLA4 DNA markers and susceptibility to type 1 diabetes in some populations, but not others. We performed case-control and family-based association studies to assess if the CTLA4 A49G and intron 1 C/T polymorphisms were associated with development of early onset type 1 diabetes in the Northern Ireland population. The distribution of A49G and C/T alleles in cases (n = 144) was similar to those observed in controls (n = 307). In contrast, significant distortions in allele transmissions from informative parents to probands were observed for both the A49G (P = 0.02) and C/T (P = 0.01) polymorphisms employing 297 nuclear families. Our results suggest that the CTLA4 gene may play a minor role in the overall genetic predisposition to type 1 diabetes in this UK population. Genes and Immunity (2001) 2, 233-235.
Insulin-dependent (type 1) diabetes mellitus (IDDM) is caused by a T cell mediated autoimmune destruction of the insulin-producing ␤ cells of the pancreas. 1 The aetiology of the disease is complex, involving several susceptibility genes and unknown environmental triggers. To date only IDDM1 (HLA-DRB1 and -DQB1 on chromosome 6p21) and IDDM2 (VNTR 5Ј to the insulin gene on chromosome 11p15) have been identified as genetic susceptibility factors 2, 3 Genome-wide linkage studies have confirmed linkage to IDDM4, IDDM5, IDDM8 and IDDM12, but other putative susceptibility loci have still to be replicated or remain controversial. [4] [5] [6] [7] [8] The IDDM12 locus at 2q33 contains the CTLA4 (cytotoxic T lymphocyte-associated 4) gene, an excellent functional candidate since the CTLA4 receptor is an important negative regulator of T cell activation. 9 Association has been found between CTLA4 gene polymorphisms and IDDM in separate family-based studies in Italian, Spanish, Mexican-American and Korean populations. 8, 10, 11 Association has also been reported between the A49G (Thr to Ala) polymorphism at position 49 in the CTLA4 gene in Belgian, German and Japanese patients, in case-control studies. 8, 12, 13 Furthermore, CTLA4 polymorphisms have been reported to be associated with predisposition to Graves' disease and Hashimoto's thyroiditis. 8, [12] [13] [14] Recently, Marron and colleagues fine-mapped the IDDM12 susceptibility locus to the D2S72-CTLA4-D2S105 region on chromosome 2q33. 11 Intrafamilial association analysis of total families (US Caucasian, European, Mexican-American and Asian) revealed linkage with two microsatellite markers (D2S72 and D2S105) flanking the CTLA4 gene and three internal markers (A49G in exon 1; C/T in intron 1 at −819 bp upstream of the exon 2 start site; (AT) n in the 3Ј untranslated region) within the gene, but not to other surrounding markers which included the CD28 gene.
11 Also, analysis of total families showed association only with the three internal CTLA4 markers, and haplotype analysis demonstrated highly significant (P = 5×10 ) distortion in transmission of a haplotype comprising the three internal CTLA4 markers 11 but not to haplotypes outside D2S72-CTLA4-D2S105. Linkage disequilibrium (LD) analysis showed strong LD between all three internal CTLA4 markers and weak LD between these markers and D2S72 and D2S105 markers, whilst LD between CTLA4 markers and others markers was either absent or declined with increasing physical and/or genetic distance. 11 Collectively, the report by Marron et al 11 as well as other reports, 8 ,10,12,13 provide compelling evidence for the IDDM12 aetiological mutation being located in or near the CTLA4 gene. In contrast, several groups have reported no association between CTLA4 polymorphisms and diabetes predisposition in UK, Sardinian, Chinese, US and Danish populations suggesting genetic heterogeneity. 8, 10, 11, 15 Interestingly however, in the large Danish family set (n = 254 families) adding the data for the A49G polymorphism to total published family data strengthened the evidence for linkage of this region to type 1 diabetes. 15 One explanation for the observed heterogeneity is that the linkage disequilibrium between the IDDM12 aetiological mutation and CTLA4 is not as tight in these populations.
In the present study we performed case-control and family-based association studies to investigate if the CTLA4 A49G and intron 1 C/T polymorphisms are associated with development of early-onset type 1 diabetes in the Northern Ireland population. A total of 144 probands and 307 controls were employed for case-control studies, and 297 trios (proband and both parents) and oldest unaffected sibling (n = 165) were included for the family studies. The probands were Caucasian and derived from a prospective register of newly diagnosed early onset cases of type 1 diabetes (diagnosed before their 15th birthday 16 ) between 1997 and 1999. Also, the under 5 age group was supplemented with trios in which the proband was registered prior to 1997. The controls comprised unrelated healthy children aged 12 to 15 years of age who were selected from a random sample of Northern Ireland schools.
Since the relative contribution of IDDM12 to genetic predisposition to type 1 diabetes appears to be small, and association may be more apparent in individuals with severe phenotype, we also stratified the genotyping data according to age-at-onset above and below 5 years of age.
The distributions of CTLA4 genotypes in cases and controls were in Hardy-Weinberg equilibrium (data not shown). No significant differences were observed in allele frequencies for the A49G and C/T polymorphisms in cases compared to controls (Table 1) . Furthermore, stratification of data according to age-at-onset of diabetes (Ͻ5 and Ͼ5) did not reveal any differences in allele distributions between case and control groups (data not shown). Consistent with previous findings by Marron and co-workers, 11 the 49G allele and intronic T allele were found to be in strong LD 17 in both cases (DЈ = 1.000) and controls (DЈ = 0.994). Genotyping for the A49G 14 and C/T 11 polymorphisms was performed on DNA samples employing PCR-restriction fragment length polymorphism typing essentially as previously described. The distribution of allele frequencies in cases and controls were compared using the 2 test. The level of statistical significance was set at 5%.
In contrast, significant transmission disequilibrium was found for the A49G polymorphism in informative families (56.5% transmissions vs 43.5% non-transmissions; P = 0.02; Table 2 ). This distortion in allele transmission, however, was only significant in patients diagnosed with type 1 diabetes before age 5 (61.5% transmissions vs 38.5% non-transmissions; P = 0.01) compared to those over 5 (53.4% transmissions vs 46.6% non-transmissions; P = 0.34; see Table 2 ). However, the difference in the distribution of allele transmissions to probands between these age groups did not attain significance (P = 0.204 for A49G; Table 2 ). The observed distortions in CTLA4 A49G allele transmissions are not likely to be due to segregation distortion since no significant distortion was found in allele transmissions to unaffected siblings (88 transmissions vs 88 non-transmissions). Family-based studies revealed virtually identical results for the C/T polymorphism (Table 2) . This is the first report of a possible association between CTLA4 A49G and intron 1 C/T polymorphisms and predisposition to type 1 diabetes in a UK population. A previous UK family-based study of similar size found no association between CTLA4 polymorphisms and development of type 1 diabetes. 8 However, it is noteworthy that in a follow-up study by Esposito and co-workers 18 a significantly increased transmission (54%) of the 280 allele of the CTLA4 (AT) n polymorphism was found in a combined UK (n = 352 families) and US (n = 236 families) family data set.
Interestingly, associations in our population were more apparent in the 0-4 age group compared to the 5-14 age group. However, since the distribution of alleles transmitted to probands did not differ significantly between cases diagnosed below and above 5 years of age, it is not possible to conclude that CTLA4 influences onset age of type 1 diabetes. Also, no significant differences in allele frequencies were observed in cases diagnosed with diabetes below 5 years of age compared to controls.
A recent UK study has reported that the increase in incidence of type 1 diabetes is more rapid in children diagnosed with the disease before 5 years of age. 19 Although this increase in incidence is likely to reflect changing environmental conditions, studies suggest that Assessment of allele transmission distortion from the expected 50:50 transmission from informative parents to offspring was performed using the transmission disequilibrium test. 22 the age-at-onset of type 1 diabetes is in part genetically determined. 20 Children diagnosed with the disease before 5 years of age are more likely to have an affected relative than children with later onset diabetes, 21 which is arguably because these children carry a greater proportion of diabetogenic alleles. The relatively high proportion of probands in the 0-4 age group (38%) employed in our family studies may have contributed to the observed associations between the CTLA4 A49G and C/T polymorphisms and development of early onset type 1 diabetes.
The observed discrepancy between our case-control and family-based data is not due to a parent-of-origin effect since we found no differences between paternal and maternal allele transmissions to probands (data not shown). There are a number of possible reasons for this disparity; (i) the positive association in the family study is a false positive, (ii) the lack of association in the casecontrol study is a false negative perhaps due to inadequate statistical power (ie, 73% power to detect the 41% (cases) vs 32% (controls) difference in G allele frequency observed in the Belgian data 8 ), or (iii) the size of the CTLA4 gene effect is small in our population and we have been fortuitous in finding a marginal association in our family studies.
Linkage disequilibrium is in part due to the frequency of the aetiological mutation and it is apparent that the frequency of the IDDM12 mutation is low in UK populations. Variable frequencies of the IDDM12 mutation between populations, together with migration patterns explain, at least in part, the observed genetic heterogeneity in different populations. The lack of association between CTLA4 DNA markers and susceptibility to type 1 diabetes in our case-control studies, together with marginal associations observed in family studies, indicate that at best the CTLA4 gene plays a minor role in susceptibility to type 1 diabetes in our population. It is important that our findings are replicated in large register-based case-control and intrafamilial association studies within the UK, and particularly in children diagnosed with the disease before 5 years of age.
